NeuroSense Therapeutics Ltd. (NRSN)

Data as of Jun 17, 2026, from SEC Form 4 filings.

No open-market insider trades (90d)Watch NRSN

See up to 3 months of NRSN. The 7-day demo opens the 1M and 3M ranges and puts NRSN on your watchlist.

Latest NRSN insider trades

Or Eisenberg - Officer
Open-market purchase$200K
Jun 16, 2026
Alon Ben-Noon - Officer
Open-market purchase$200K
Jun 16, 2026
Or Eisenberg - Officer

About NeuroSense Therapeutics Ltd. (NRSN)

NeuroSense Therapeutics Ltd. is an SEC registrant, filing under CIK 0001875091, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.

Sector: Health Care

SEC filings for NRSN on EDGAR

NRSN Form 4 activity by transaction type, last 90 days

No Form 4 activity for NRSN in the last 90 days.

NRSN insider transactions (Form 4)

5 Form 4 filings on record, the earliest from Mar 30, 2026, newest first.

Date	Insider	Transaction	Security	Shares	Price	Value
Jun 16, 2026	Or Eisenberg - Officer	Open-market purchase	Ordinary Shares	250,000	$0.80	$200K
Jun 16, 2026	Alon Ben-Noon - Officer	Open-market purchase	Ordinary Shares	250,000	$0.80	$200K
Mar 26, 2026	Or Eisenberg - Officer	Grant or award	Ordinary Shares	200,000^{footnote F1}	$0.00	-
Footnote F1 (shares): The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date.
Mar 26, 2026	Niva Russek-Blum - Officer	Grant or award	Ordinary Shares	200,000^{footnote F2}	$0.00	-
Footnote F2 (shares): The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date.
Mar 26, 2026	Hagit Binder - Officer	Grant or award	Ordinary Shares	200,000^{footnote F2}	$0.00	-
Footnote F2 (shares): The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

NRSN insider trading FAQ

What is the latest insider trade for NRSN?

NeuroSense Therapeutics Ltd. (NRSN) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-17. The full record for NRSN runs to 5 Form 4 filings, the earliest from 2026-03-30. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying NRSN stock?

No insider purchases of NRSN were filed in the last 90 days. 2 purchases are on record for this company.

How many insiders are selling NRSN stock?

No insider sales of NRSN were filed in the last 90 days.

Where can I see NRSN SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects NRSN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Jun 17, 2026 - Or Eisenberg view on EDGAR
Jun 17, 2026 - Alon Ben-Noon view on EDGAR
Apr 1, 2026 - Or Eisenberg view on EDGAR
Mar 30, 2026 - Niva Russek-Blum view on EDGAR
Mar 30, 2026 - Hagit Binder view on EDGAR

Related companies with recent insider activity

Learn more

What the Form 4 transaction codes mean: Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
Insider activity in Health Care: Where NRSN's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow NRSN with a 7-day demo

NRSN on your watchlist
Every NRSN Form 4 filing on record
Up to 3 months of NRSN price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Date

Insider

Transaction

Security

Price

Value

Jun 16, 2026

Or Eisenberg - Officer

Open-market purchase

Ordinary Shares

250,000

$0.80

$200K

Jun 16, 2026

Alon Ben-Noon - Officer

Open-market purchase

Ordinary Shares

250,000

$0.80

$200K

Mar 26, 2026

Or Eisenberg - Officer

Grant or award

Ordinary Shares

200,000^{footnote F1}

$0.00

Footnote F1 (shares): The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Mar 26, 2026

Niva Russek-Blum - Officer

Grant or award

Ordinary Shares

200,000^{footnote F2}

$0.00

Footnote F2 (shares): The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Mar 26, 2026

Hagit Binder - Officer

Grant or award

Ordinary Shares

200,000^{footnote F2}

$0.00

Footnote F2 (shares): The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date.